跳至主要内容
临床试验/ISRCTN27914471
ISRCTN27914471已完成不适用

A comparison of the efficacy and effectiveness of dihydroartemisinin-piperaquine and artesunate-mefloquine in the treatment of falciparum malaria

Doctors Without Borders (Medecins sans Frontieres [MSF]) (The Netherlands)0 个研究点目标入组 640 人开始时间: 2006年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
640

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with fever (axillary temperature >37.5°C), or a history of fever within 48 hours
  • 2. Confirmed falciparum malaria (mixed infection P. falciparum with P. vivax and/or P. malariae were included), with more than 500 but less than 100,000 asexual parasites per ml

排除标准

  • 1. Signs of severe and complicated malaria
  • 2. Children below one-year-old
  • 3. Pregnant women
  • 4. Patients with a history of taking mefloquine during the previous two months
  • 5. Patients taken any other antimalarial drugs in the previous 48 hours
  • 6. Patients with a history of psychiatric diseases

研究者

发起方
Doctors Without Borders (Medecins sans Frontieres [MSF]) (The Netherlands)

相似试验